...
首页> 外文期刊>Clinical Drug Investigation >Staff Time and Motion Assessment for Administration of Erythropoiesis-Stimulating Agents: A Two-Phase Pilot Study in Clinical Oncology Practices
【24h】

Staff Time and Motion Assessment for Administration of Erythropoiesis-Stimulating Agents: A Two-Phase Pilot Study in Clinical Oncology Practices

机译:促红细胞生成剂管理的工作人员时间和运动评估:临床肿瘤学实践的两阶段先导研究

获取原文
获取原文并翻译 | 示例
           

摘要

Background Erythropoiesis-stimulating agents (ESAs) are used for the management of anaemia in patients with non-myeloid malignancies where anaemia is due to the effect of concomitant myelosuppressive chemotherapy. Assessing the impact of different ESA dosing regimens on office staff time and projected labour costs is an important component of understanding the potential for optimization of oncology practice efficiencies.
机译:背景促红细胞生成素刺激剂(ESA)用于治疗非骨髓性恶性肿瘤患者的贫血,在这些患者中,贫血归因于骨髓抑制性化疗的影响。评估不同的ESA给药方案对办公室工作人员时间和预计的人工成本的影响,是了解优化肿瘤实践效率潜力的重要组成部分。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号